Usefulness of bone resorption markers in hemodialysis patients
Authors:
- Takayuki HamanoTHTakayuki Hamano
- Kodo TomidaKTKodo Tomida
- Satoshi MikamiSMSatoshi Mikami
- Isao MatsuiIMIsao Matsui
- Naohiko FujiiNFNaohiko Fujii
- Enyu ImaiEIEnyu Imai
- Hiromi RakugiHRHiromi Rakugi
- Yoshitaka IsakaYIYoshitaka Isaka
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Serum Alkaline Phosphatase Predicts Mortality among Maintenance Hemodialysis PatientsJournal of the American Society of Nephrology, 2008
- High alkaline phosphatase levels in hemodialysis patients are associated with higher risk of hospitalization and deathKidney International, 2008
- Utility of serum tartrate‐resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: independence from renal dysfunctionClinical Endocrinology, 2008
- Reference intervals of serum tartrate-resistant acid phosphatase type 5b activity measured with a novel assay in Japanese subjectsJournal of Bone and Mineral Metabolism, 2008
- Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney diseaseBone, 2006
- Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTHLife Sciences, 2005
- Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patientsBone, 2005
- Tartrate-Resistant Acid Phosphatase 5b: A Novel Serum Marker of Bone ResorptionJournal of Bone and Mineral Research, 2000
- Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathwayEndocrinology, 1996
- Reconstruction of the resorptive site in iliac trabecular bone: A kinetic model for bone resorption in 20 normal individualsMetabolic Bone Disease and Related Research, 1984